Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 2CNS 1

Conditions

Neurofibromatosis 1 1Neurofibromatoses 1Neoplasm Metastasis 1Melanoma 1Cutaneous Metastases 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × diphenylcyclopropenone × Clear all
NCT05481658 2026-02-10

Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous Metastases

Icahn School of Medicine at Mount Sinai

Phase 1 Recruiting
100 enrolled
Dermatologic

Cutaneous Metastases

NCT05438290 2024-05-06

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Icahn School of Medicine at Mount Sinai

Phase 1 Completed
17 enrolled
CNS

Neurofibromatosis 1, Neurofibromatoses

NCT01711684 2017-11-29

Treatment of Cutaneous Metastases With Diphenylcyclopropenone (DPCP)

Rockefeller University

Phase 1 Completed
6 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡